Seer (SEER) Competitors $2.10 -0.03 (-1.41%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$2.10 +0.00 (+0.24%) As of 07/15/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SEER vs. LAB, CTKB, AEHR, QSI, QTRX, SENS, MASS, FEIM, KEQU, and RPIDShould you be buying Seer stock or one of its competitors? The main competitors of Seer include Standard BioTools (LAB), Cytek Biosciences (CTKB), Aehr Test Systems (AEHR), Quantum-Si (QSI), Quanterix (QTRX), Senseonics (SENS), 908 Devices (MASS), Frequency Electronics (FEIM), Kewaunee Scientific (KEQU), and Rapid Micro Biosystems (RPID). These companies are all part of the "measuring and control equipment" industry. Seer vs. Its Competitors Standard BioTools Cytek Biosciences Aehr Test Systems Quantum-Si Quanterix Senseonics 908 Devices Frequency Electronics Kewaunee Scientific Rapid Micro Biosystems Seer (NASDAQ:SEER) and Standard BioTools (NASDAQ:LAB) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation. Do analysts recommend SEER or LAB? Seer currently has a consensus target price of $3.00, suggesting a potential upside of 42.86%. Standard BioTools has a consensus target price of $2.50, suggesting a potential upside of 104.92%. Given Standard BioTools' stronger consensus rating and higher probable upside, analysts plainly believe Standard BioTools is more favorable than Seer.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Seer 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Standard BioTools 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has better earnings and valuation, SEER or LAB? Seer has higher earnings, but lower revenue than Standard BioTools. Standard BioTools is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSeer$14.17M8.72-$86.60M-$1.41-1.49Standard BioTools$174.43M2.66-$138.88M-$0.35-3.49 Does the media favor SEER or LAB? In the previous week, Seer had 5 more articles in the media than Standard BioTools. MarketBeat recorded 6 mentions for Seer and 1 mentions for Standard BioTools. Standard BioTools' average media sentiment score of 1.89 beat Seer's score of 0.10 indicating that Standard BioTools is being referred to more favorably in the news media. Company Overall Sentiment Seer Neutral Standard BioTools Very Positive Is SEER or LAB more profitable? Standard BioTools has a net margin of -78.24% compared to Seer's net margin of -560.90%. Standard BioTools' return on equity of -22.44% beat Seer's return on equity.Company Net Margins Return on Equity Return on Assets Seer-560.90% -24.69% -22.13% Standard BioTools -78.24%-22.44%-16.74% Which has more volatility and risk, SEER or LAB? Seer has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500. Comparatively, Standard BioTools has a beta of 1.54, suggesting that its share price is 54% more volatile than the S&P 500. Do institutionals & insiders have more ownership in SEER or LAB? 75.2% of Seer shares are held by institutional investors. Comparatively, 53.7% of Standard BioTools shares are held by institutional investors. 11.3% of Seer shares are held by company insiders. Comparatively, 23.2% of Standard BioTools shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryStandard BioTools beats Seer on 10 of the 16 factors compared between the two stocks. Get Seer News Delivered to You Automatically Sign up to receive the latest news and ratings for SEER and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SEER and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SEER vs. The Competition Export to ExcelMetricSeerMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$125.39M$2.96B$5.61B$9.30BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-1.4920.2228.5219.58Price / Sales8.72290.74426.1793.37Price / CashN/A43.1536.0257.93Price / Book0.387.568.135.54Net Income-$86.60M-$55.11M$3.24B$257.73M7 Day Performance-3.23%3.81%0.20%-0.08%1 Month Performance3.96%11.60%5.98%8.09%1 Year Performance8.81%-2.11%26.15%13.02% Seer Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SEERSeer2.2174 of 5 stars$2.10-1.4%$3.00+42.9%+14.8%$125.39M$14.17M-1.49160LABStandard BioTools3.7992 of 5 stars$1.28-5.2%$2.50+95.3%-42.2%$512.76M$174.43M-3.66620Positive NewsCTKBCytek Biosciences3.0465 of 5 stars$3.40-9.6%$5.60+64.7%-48.7%$476.24M$200.45M-37.77500News CoverageAEHRAehr Test Systems3.4364 of 5 stars$14.82-5.0%$25.00+68.7%-14.5%$464.43M$66.22M19.0090QSIQuantum-Si1.8186 of 5 stars$1.83-14.5%$3.48+89.9%+59.3%$392.69M$3.06M-2.69150Gap UpQTRXQuanterix2.569 of 5 stars$6.30-9.7%$15.60+147.6%-63.6%$348.68M$137.42M-4.85460SENSSenseonics2.0065 of 5 stars$0.49-2.6%$1.55+216.8%+11.3%$320.11M$23.68M-3.7690News CoverageAnalyst ForecastAnalyst RevisionMASS908 Devices1.1195 of 5 stars$6.41-3.6%$5.33-16.8%+17.5%$238.48M$59.63M-11.8760Positive NewsFEIMFrequency Electronics1.5876 of 5 stars$20.82-2.8%N/A+105.4%$207.17M$55.27M8.64200Earnings ReportUpcoming EarningsHigh Trading VolumeKEQUKewaunee Scientific0.9701 of 5 stars$58.42-0.7%N/A+10.8%$167.41M$240.47M15.251,239Positive NewsRPIDRapid Micro Biosystems2.1489 of 5 stars$3.49-3.9%$8.00+129.2%+400.0%$159.11M$28.05M-3.39200News Coverage Related Companies and Tools Related Companies Standard BioTools Alternatives Cytek Biosciences Alternatives Aehr Test Systems Alternatives Quantum-Si Alternatives Quanterix Alternatives Senseonics Alternatives 908 Devices Alternatives Frequency Electronics Alternatives Kewaunee Scientific Alternatives Rapid Micro Biosystems Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SEER) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seer, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SEER Stock Alerts